Abstract:AIMTo construct ltB-ureB fusion gene and its prokaryotic expression system and identify immunity and adjuvanticity of the expressed recombinant protein.METHODSThe ureB gene from a clinical Helicobacter pylori (H pylori) strain Y06 and the ltB gene from Escherichia coli (E. coli) strain 44851 were linked into ltB-ureB fusion gene by PCR. The fusion gene sequence was analyzed after T-A cloning. A prokaryotic recombinant expression vector pET32a inserted with ltB-ureB fusion gene (pET32a-ltB-ureB) was constructed. Expression of the recombinant LTB-UreB protein (rLTB-UreB) in E. coli BL21DE3 induced by isopropylthio-beta-D-galactoside (IPTG) at different concentrations was detected by SDS-PAGE. Western blot assays were used to examine the immunoreaction of rLTB-UreB by a commercial antibody against whole cell of H pylori and a self-prepared rabbit anti-rUreB serum, respectively, and determine the antigenicity of the recombinant protein on inducing specific antibody in rabbits. GM1-ELISA was used to demonstrate the adjuvanticity of rLTB-UreB. Immunoreaction of rLTB-UreB to the UreB antibody positive sera from 125 gastric patients was determined by using ELISA.RESULTSIn comparison with the corresponding sequences of original genes, the nucleotide sequence homologies of the cloned ltB-ureB fusion gene were 100%. IPTG with different dosages of 0.1-1.0 mmol/L could efficiently induce pET32a-ltB-ureB-E.coli BL21DE3 to express the rLTB-UreB. The output of the target recombinant protein expressed by pET32a-ureB-E.coli BL21DE3 was approximately 35% of the total bacterial proteins. rLTB-UreB mainly presented in the form of inclusion body. Western blotting results demonstrated that rLTB-UreB could combine with the commercial antibody against whole cell of H pylori and anti-rUreB serum as well as induce rabbit to produce specific antibody. The strong ability of rLTB-UreB binding bovine GM1 indicated the existence of adjuvanticity of the recombinant protein. All the UreB antibody positive sera from the patients (125/125) were positive for rLTB-UreB.CONCLUSIONA recombinant prokaryotic expression system with high expression efficiency of the target fusion gene ltB-ureB was successfully established. The expressed rLTB-UreB showed qualified immunogenicity, antigenicity and adjuvanticity. All the results mentioned above laid a firm foundation for further development of H pylori genetically engineered vaccine.

Construction of high level prokaryotic expression and purification system of PD-L1 extracellular domain by using Escherichia coli host cell machinery

Development of a Sandwich ELISA for Evaluating Soluble PD-L1 (CD274) in Human Sera of Different Ages As Well As Supernatants of PD-L1+ Cell Lines

Preparation and characterization of a novel monoclonal antibody against human PD-1

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Construction of Recombinant pDsRed-LC3 Fusion Protein and Its Expression and Localization in HepG2 Cell

High-level Expression,Purification and Activity of the Plectasin

High Level Soluble Expression and One-Step Purification of IBDV VP2 Protein in Escherichia Coli

Construction and Expression of Procaryotic Expression Vector of a Chimeric GPI-B7-1 Cdna

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

Prokaryotic Expression of Endostat in and Preparation of Polyclonal Antibody

High-Level Expression, Purification, Polyclonal Antibody Preparation Against Recombinant Oprd from Pseudomonas Aeruginosa

Construction of Prokaryotic Expression System of Ltb-Ureb Fusion Gene and Identification of the Recombinant Protein Immunity and Adjuvanticity

Bioengineering and Computational Analysis of Programmed Cell Death Ligand-1 Monoclonal Antibody.

Prokaryotic expression,purification of PEB1 in Campylobacter jejuni and preparation of its polyclonal antibody

Expression, purification and refolding of pro-MMP-2 from inclusion bodies of E. coli

Efficient Development and Expression of Scfv Recombinant Proteins Against PD-L1 Surface Domain and Potency in Cancer Therapy

Construction, Expression and Purification of HIV-1 P24-Gp41 Fusion Protein in E.coli

Expression, Purification and Activity Analysis of a New Fusion Protein As an Immune Attenuator

Development of a protein-solubilizing expression method based on the synergistic action of intein ΔI-CM and the solubility enhancer elastin-like polypeptide

Expression of human prostate specific antigen in Escherichia coli and preparation of PSA polyclonal antibody